Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | BMC Medicine

Fig. 5

From: Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial

Fig. 5

Analysis of in vitro intra-hepatic sporozoite development inhibition by CPS-induced antibodies, cellular responses and protection status in vivo. CPS-induced antibody-mediated inhibition of in vitro challenge strain intra-hepatic development and cytotoxic and cytokine-producing T cell responses to NF54-infected erythrocytes are shown. The 10th and 90th percentile of each response in all (n = 19) CPS-immunized volunteers that received a heterologous challenge infection are shown as grey box-and-whisker plots. The green triangle represents 1 out of 9 CPS-immunized volunteers sterilely protected against NF166.C8 challenge infection, while the orange square and upside down triangle represent the 2 out of 10 CPS-immunized volunteers with sterile protection against NF135.C10 challenge infection

Back to article page